Farah Nabil and Saleem, M. (2026) “First-Line FOLFIRINOX vs Gemcitabine ± Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma: Real-World Treatment Response and Clinicopathologic Predictors from a 2022 Tertiary-Center Cohort”, Middle Eastern Cancer and Oncology Journal, 2(2), pp. 11–17. doi:10.61706/MECOJ160191.